Advertisement.

CSPHF Projected Dividend Yield

USD Shs/Cstone Pharmaceuticals ( OTCBB : CSPHF )

Cstone Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology and medicines to address the medical needs of cancer patients. Co. product include: GAVRETO® (pralsetinib), a rearranged during transfection (RET) inhibitor for the treatment of adults with locally advanced or metastatic RET fusion-positive non-small cell lung cancer; AYVAKIT® (avapritinib), which is a KIT/PDGFRA inhibitor for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutations; and CEJEMLY® (sugemalimab), which is an investigational monoclonal antibody directed against PD-L1.

21 YEAR PERFORMANCE RESULTS

CSPHF Dividend History Detail
CSPHF Dividend News
CSPHF Competitors News

# of Shares: 0

Closing Price: 0.52

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000